Enteral Nutrition After Pancreaticoduodenectomy
Cancer of Pancreas, Cancer of Duodenum, Ampulla of Vater Cancer
About this trial
This is an interventional prevention trial for Cancer of Pancreas
Eligibility Criteria
Inclusion Criteria:
Patients underwent selective pancreaticoduodenectomy Patients ≥18 years old and ≤80 years old Having given written informed consent
Exclusion Criteria:
Previous gastric resection or intestinal reconstruction Preoperative complete parenteral or enteral feeding ASA score ≥4 Pregnant women Severe malnutrition Patient who cannot give written informed consent.
Sites / Locations
- The first affiliated hospital of Nanjing Medical University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Placebo Comparator
Other
Early enteral nutrition
Saline Group
ERAS Group
Nasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Nasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
Nasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.